Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-185,290
Closed -$1.56M 592
2024
Q4
$1.56M Sell
185,290
-48,514
-21% -$375K 0.43% 74
2024
Q3
$1.84M Buy
233,804
+95,232
+69% +$857K 0.49% 59
2024
Q2
$1.43M Sell
138,572
-201,592
-59% -$2.18M 0.52% 55
2024
Q1
$4.26M Buy
340,164
+262,977
+341% +$3.4M 1.84% 4
2023
Q4
$1.18M Buy
77,187
+14,643
+23% +$205K 0.42% 75
2023
Q3
$918K Sell
62,544
-10,986
-15% -$171K 0.31% 100
2023
Q2
$1.3M Buy
73,530
+19,374
+36% +$329K 0.27% 97
2023
Q1
$964K Buy
+54,156
New +$1.01M 0.32% 94

Other funds holding TBI

Numerai's TBI Position: Q1 2025 in Review

Numerai sold out of Trueblue (TBI) in Q1 2025, closing a stake of 185,290 shares — an estimated $1.56M sold.

Numerai first reported a position in TBI in Q1 2023 and held it in 8 quarters. The position peaked at $4.26M in Q1 2024. 112 funds tracked by Wall St. Rank hold TBI as of Q1 2025.

  • Numerai reported no remaining Trueblue position as of Q1 2025 after selling out during the quarter.
  • Numerai sold 185,290 Trueblue shares in Q1 2025, an estimated $1.56M.
  • Numerai first reported a position in Trueblue in Q1 2023 and held it in 8 quarters.
  • Numerai's Trueblue position peaked at $4.26M in Q1 2024.
  • 112 funds tracked by Wall St. Rank held Trueblue as of Q1 2025.

Based on Numerai's 13F filing for Q1 2025, filed 15 May 2025.